Skip to main content

Table 1 Demographics data at the induction treatment with rituximab

From: Rituximab in relapsing and de novo MPO ANCA-associated vasculitis with severe renal involvement: a case series

Patient

Gender

Age

Vasculitis type

Relapse/De novo/

Kidney biopsy (IWGRP)a

CrClb (ml/min)

BVASc

PE

HD

Time between CYC and RTX (months)

1

x

d

MPA Renal limited

Relapse

Crescentic

24

8

NO

NO

66

2

x

c

GPA

Relapse

Sclerotic

25

13

NO

NO

60

3

x

d

MPA Renal limited

Relapse

Crescentic

15

6

NO

NO

4

4

x

b

MPA

Relapse

Mixed

13

14

YES

NO

8

5

x

b

MPA

De novo

NAd

4

16

YES

YES

NAd

6

x

a

MPA

De novo

NAd

< 5

21

NO

YES

NAd

7

y

c

MPA

De novo

Mixed

22

21

NO

NO

NAd

8

x

d

MPA

De novo

Crescentic

11

12

NO

NO

NAd

  1. aIWGRP: International Working Group of Renal Pathologists
  2. bCreatinine clearance (ml/min)
  3. cBirmingham Vasculitis Activity Score (version 3)
  4. dNot applicable
  5. Age: a (18–29), b (30–45), c (55–64), d (> 70)